Abbott

Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

  • by

Shots: The US FDA has approved NeuroSphere Virtual Clinic that allows a patient to communicate with a physician and remotely receive stimulation settings in real time regardless of location NeuroSphere Virtual Clinic allows clinicians to provide new treatment settings remotely to the patient’s neurostimulation device… Read More »Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening

  • by

Shots: Abbott received a CE mark for asymptomatic testing and self-swabbing using its Panbio COVID-19 Ag test to detect SARS-CoV-2. Abbott has shipped 200M test to 120 countries globally The test is approved with a patient-friendly and minimally invasive nasal swab, i.e. patients can self-administer… Read More »Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening

PharmaShots Weekly Snapshots (Jan 11 – 15, 2021)

  • by

Novartis’ Ligelizumab (QGE031) Receives the US FDA’s Breakthrough Designation for Patients with Chronic Spontaneous Urticaria Published: Jan 15, 2020 | Tags: Novartis’, Ligelizumab (QGE031), Receives ,US FDA’s, Breakthrough Designation for Patients , Chronic Spontaneous Urticaria Philips Collaborates with Merck KGaA to Advance Personalized Fertility Treatment… Read More »PharmaShots Weekly Snapshots (Jan 11 – 15, 2021)

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

  • by

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology… Read More »Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients

  • by

Abbott recently released global research on vascular patient care, designed to shine a light on the vascular patient journey. The report called “Beyond Intervention” uncovers the universal challenges faced by physicians who deliver vascular care, their patients, and the hospital administrators who support them. It… Read More »How Data-Driven Technology Holds The Promise of Better Outcomes for Vascular Patients

Abbott’s IOS-Compatible App Receives the US FDA’s Approval for Patients with Neurological Disorder

  • by

Shots: The US FDA approves Abbott’s patient controller app for use on Apple’s smartphone devices, allowing patients with neurological conditions such as chronic pain or movement disorders to manage their therapy directly from their smartphone The company plans to integrate the app into Abbott’s NeuroSphere… Read More »Abbott’s IOS-Compatible App Receives the US FDA’s Approval for Patients with Neurological Disorder

COVID-19 Infects Patient & Practitioner Demands, Unsettling the Future of Hospital Operations

  • by

Eric Stone, Co-Founder & CEO at Velano Vascular Prior to the outbreak of COVID-19, the healthcare industry in the United States was in the midst of an intense refocusing on patient-centered care. This evolution was defined by a number of innovations, policies, and even federal reimbursement… Read More »COVID-19 Infects Patient & Practitioner Demands, Unsettling the Future of Hospital Operations